Stryker said OrthoSensor’s Verasense intraoperative sensor technology will further boost Mako surgical robots, enhancing workflow through one complete data-driven feedback mechanism.
Top 10 transactions in robotics in 2020
Robotics investments recap: May 2020
Although May 2020 was a relatively slow month for robotics transactions, autonomous vehicle companies such as Waymo, Didi Chuxing, and Tesla continued to receive investments.
6 types of surgical procedures getting robotic assistance
The range of surgical procedures that robots can assist is widening, even as systems become more specialized.
Robotics investments recap: September 2019
In September 2019, the biggest robotics deals were in healthcare, followed by self-driving cars and service robots.
Stryker acquires Mobius Imaging, Cardan Robotics for $500M
Stryker, a leading medical technology company based in Kalamazoo, Michigan, acquired Mobius Imaging and its subsidiary Cardan Robotics for $500 million. The deal includes a down payment of $370 million in cash and $130 million that will be paid based on development and commercialization milestones. Shirley, Mass.-based Mobius develops point-of-care imaging technology. Its Airo TruCT…
7 companies transforming orthopedics with robot-assisted surgery
Orthopedic device companies have been actively developing products for surgical robotics, several through acquisitions.
Stryker strives for market share in orthopedic surgery robots
Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology.
Robotics investments recap: March 2019
Investments in robots, autonomous vehicles, and related systems totaled at least $1.3 billion in March 2019, down from $4.3 billion in February. On the other hand, automation companies reported $7.8 billion in mergers and acquisitions last month. While that may represent a slowdown, note that many businesses did not specify the amounts involved in their…
Stryker adds OrthoSpace to surgical portfolio for sports medicine
Stryker Corp. said today that it is acquiring OrthoSpace Ltd. and its InSpace rotator cuff repair device for $220 million. Kalamazoo, Mich.-based Stryker said it paid $110 million in cash upfront and agreed to another $110 million in potential milestones for Caesarea, Israel-based OrthoSpace. “The acquisition of OrthoSpace is highly complementary to our existing portfolio…
Stryker launches Mako robotic platform total-knee application
Stryker (NYSE:SYK) said today it launched the robotic-arm assisted total knee arthroplasty application for use with its Mako System, touting it as the 1st and only robotic technology which can be used for total knee, hip and partial knee replacement procedures. The Kalamazoo, Mich.-based company’s Mako Total Knee utilizes both Stryker’s robotic platform and its Triathlon…
Analyst: Uptake for robotic knee procedures will depend more on marketing than evidence
The adoption of robot-assisted total knee replacements will depend more on marketing that data or outcomes, Leerink Partners analysts wrote yesterday, as the leading contenders prepare to unveil their robotic total knee systems at an upcoming orthopedics conference. Based on a conference call with a pair of orthopedic surgeons who each perform roughly 200 knee…
11 surgical robotics companies you need to know
Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find out more.…
Stryker gains on Q4 prelims
Stryker (NYSE:SYK) shares are up after the orthopedics and hospital equipment giant posted preliminary financial results for the 4th quarter that narrowly beat the consensus forecast on Wall Street. The Kalamazoo, Mich.-based company said it expects a total revenue of $3.2 billion for Q4, up 16.3% from the same time last year. Analysts were looking for sales…
Analyst: There’s a ‘mismatch’ between expectations and reality for Stryker’s Mako platform
A 51-physician Barclays survey of U.S. hip and knee surgeons today prompted analyst Matthew Taylor to question investors’ expectations for Stryker‘s (NYSE:SYK) Mako robot-assisted surgery platform. Some 22% of the docs surveyed reported using the Mako system, most for partial knee replacement procedures, with 25.5% saying they would use it more in the future, Taylor…